Echocardiographic Findings in HFpEF
In HFpEF, echocardiography must demonstrate preserved or only mildly reduced LVEF (≥45-50%) combined with evidence of diastolic dysfunction, structural cardiac abnormalities, or elevated filling pressures to confirm the diagnosis. 1
Essential Diagnostic Criteria
The diagnosis of HFpEF requires three mandatory echocardiographic conditions to be satisfied 1:
- Preserved LV systolic function: LVEF ≥45-50% 1
- Evidence of diastolic dysfunction: Abnormal LV relaxation or diastolic stiffness 1
- Structural or functional cardiac abnormalities (detailed below) 1
Key Structural Findings
According to the European Society of Cardiology guidelines, five core structural parameters should be assessed 1:
- Left atrial volume index (LAVI): Typically elevated, reflecting chronic elevation of filling pressures 1
- Left ventricular mass index (LVMI): Often increased, indicating LV hypertrophy 1
- Left ventricular hypertrophy: Common finding representing structural remodeling 2
- Tricuspid regurgitation velocity (TRV): Elevated pulmonary artery pressure >35 mmHg is frequently present 1, 2
Diastolic Function Parameters
Mitral Inflow Patterns (E/A Ratio)
Three distinct abnormal filling patterns are recognized in sinus rhythm 1:
Impaired relaxation pattern (E/A <1): Decreased peak E-velocity with compensatory increase in A-velocity, indicating early diastolic dysfunction with normal or low filling pressures 1
Restrictive filling pattern (E/A >2, deceleration time 115-150 ms): Elevated peak E-velocity with short deceleration time, indicating high filling pressures and advanced disease 1
Pseudonormal pattern (E/A >1): Intermediate pattern that appears normal but masks elevated filling pressures; can be unmasked with Valsalva maneuver 1
Tissue Doppler Imaging (E/e' Ratio)
E/e' is the most established and prognostically validated parameter in HFpEF, though it has only modest correlation with invasive filling pressures (r=0.56). 1
- E/e' >15: Indicates high filling pressures 1
- E/e' <8: Suggests low filling pressures 1
- E/e' 8-15: Inconclusive, requires integration with other parameters 1
Critical caveat: E/e' should never be used in isolation to diagnose HFpEF, as it has poor sensitivity (36-64%) despite reasonable specificity (73-89%) for elevated filling pressures. 1 The 2018 systematic review demonstrated that E/e' has only modest prognostic value (HR 1.05 per unit increase for mortality/cardiovascular hospitalization). 1
Myocardial Tissue Velocity (e')
- Reduced e' velocity (<8-9 cm/s septal, <10 cm/s lateral): Indicates impaired LV relaxation 1
- Measured at septal and/or lateral mitral annulus 1
Additional Doppler Parameters
The ESC guidelines detail multiple supplementary Doppler indices 1:
- Pulmonary vein flow: S wave >D wave suggests low filling pressures; reversed pattern indicates elevated pressures 1
- (A mitral - A pulmonary) duration: <30 ms indicates high filling pressures; >30 ms suggests normal pressures 1
- Flow propagation velocity (Vp): <45 cm/s indicates slow relaxation 1
- E/Vp ratio: >2.5 suggests high filling pressures; <2 indicates low pressures 1
Advanced Echocardiographic Techniques
Speckle-Tracking Echocardiography
Global longitudinal strain (GLS) is reduced in HFpEF patients compared to controls, even with preserved LVEF, providing sensitive detection of subclinical systolic dysfunction. 1, 3
- Patients with HFpEF demonstrate lower longitudinal and circumferential strains compared to hypertensive heart disease patients 1
- During exercise, LV longitudinal strain is significantly reduced in HFpEF (-17±5%) versus controls (-22±4%) 4
- GLS provides prognostic information and aids in phenotyping HFpEF 3
Exercise Stress Echocardiography
Exercise stress echo is valuable for diagnosing HFpEF in patients with unexplained dyspnea who lack overt congestion at rest (approximately 35% of HFpEF patients). 5, 6, 4
During submaximal exercise testing in HFpEF patients 4:
- LV longitudinal diastolic relaxation (e') is reduced: 9±2 cm/s versus 15±4 cm/s in controls
- RV longitudinal systolic function (RV s') is impaired: 14±3 cm/s versus 18±1 cm/s in controls
- LV afterload (arterial elastance) correlates with decreased LV longitudinal strain (R=0.51)
Integrated Assessment Approach
No single echocardiographic parameter can reliably diagnose HFpEF; an integrated assessment of multiple markers is mandatory. 1 The guidelines emphasize combining:
- Structural parameters (LAVI, LVMI) 1
- Diastolic function indices (E/A, E/e', e') 1
- Hemodynamic markers (TRV, pulmonary pressures) 1, 2
- Clinical characteristics and natriuretic peptides 5, 6
Common Pitfalls to Avoid
- Do not rely solely on E/e' for diagnosis, as it has limited diagnostic accuracy in HFpEF populations 1
- Recognize pseudonormal patterns: Use Valsalva maneuver to unmask elevated filling pressures when E/A appears normal 1
- Consider exercise testing when resting echo is inconclusive, particularly in patients with unexplained dyspnea 5, 4
- Use contrast agents only when ≥2 contiguous LV segments are poorly visualized, not routinely 1
- Remember that HFpEF and diastolic dysfunction are not identical: HFpEF requires clinical symptoms plus objective evidence 1